Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

Press releases published on November 3, 2026

Nov. 3, 2026

City Therapeutics to Present at Upcoming November Investor Conferences 

Indeterminate GlobeNewswire

Nov. 3, 2026

Paradise uRDN System Demonstrates 19.5 mmHg Blood Pressure Reduction at 12 Months, with Durability Through 4 Years

Indeterminate GlobeNewswire

Nov. 3, 2026

Intellia Therapeutics Announces Upcoming Nexiguran Ziclumeran (nex-z) Medical Congress Presentations

Indeterminate GlobeNewswire

Nov. 3, 2026

Claria System Study Earns AAGL’s Jordan M. Phillips Award for Top-Scoring MIGS Research

Indeterminate GlobeNewswire

Nov. 3, 2026

Allogene Highlights Clinical Progress and Next-Generation Innovation Across Its Off-the-Shelf CAR T Platform at SITC Annual Meeting

Indeterminate GlobeNewswire

Nov. 3, 2026

Children’s Healthcare Canada releases Start Strong, a National Playbook to Transform Child and Youth Health Systems

Indeterminate GlobeNewswire

Nov. 3, 2026

Phathom Pharmaceuticals Announces Eligible Commercially Insured Patients May Now Pay as Little as $0 for VOQUEZNA® (vonoprazan) Tablets Exclusively at BlinkRx

Indeterminate GlobeNewswire

Nov. 3, 2026

Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

Santé des enfants Canada publie Le meilleur départ, une feuille de route nationale pour transformer les systèmes de santé des enfants et des jeunes

Indeterminate GlobeNewswire

Nov. 3, 2026

Lean On Launches Nutritional Supplement Line for People Using GLP-1 Medications

Indeterminate GlobeNewswire

Nov. 3, 2026

Bolt Biotherapeutics to Participate in Upcoming Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

4DMT to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

Septerna to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Humacyte Innovative Research in Coronary Bypass and Vascular Regeneration to be Highlighted at American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

Geron Corporation to Participate in the Stifel 2026 Healthcare Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

CalciMedica to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

UroGen Pharma to Present at the Guggenheim Securities 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

Oryzon announces authorization in Spain of VIVALDI, a collaborative clinical study with CETLAM to evaluate iadademstat in combination with standard-of-care therapy in high-risk newly-diagnosed AML subpopulations

Indeterminate GlobeNewswire

Nov. 3, 2026

Ardelyx Completes Enrollment in Phase 3 ACCEL Clinical Trial of IBSRELA® (tenapanor) in Adults with Chronic Idiopathic Constipation

Indeterminate GlobeNewswire